Incyte CorpNASDAQ:INCY
- LAST PRICE65.8200
- TODAY'S CHANGE (%)0.6900 (1.0594%)
- Bid / Lots65.8300/ 3
- Ask / Lots66.6300/ 1
- Open / Previous Close65.6400 / 65.1300
- Day Range
- 52 Week Range
- Volume1,568,929
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | INCY |
|---|---|---|
| 09:32 ET | 19003 | 65.855 |
| 09:34 ET | 3100 | 65.86 |
| 09:36 ET | 1600 | 65.93 |
| 09:38 ET | 2675 | 66.115 |
| 09:39 ET | 828 | 65.99 |
| 09:41 ET | 1888 | 66.06 |
| 09:43 ET | 1205 | 66.17 |
| 09:45 ET | 23479 | 66.23 |
| 09:48 ET | 3238 | 66.37 |
| 09:50 ET | 13603 | 66.14 |
| 09:52 ET | 2353 | 65.98 |
| 09:54 ET | 27046 | 66.13 |
| 09:56 ET | 4650 | 66.15 |
| 09:57 ET | 1402 | 66.06 |
| 09:59 ET | 3493 | 66.16 |
| 10:01 ET | 3200 | 66.25 |
| 10:03 ET | 3424 | 66.41 |
| 10:06 ET | 4813 | 66.4 |
| 10:08 ET | 5323 | 66.705 |
| 10:10 ET | 33656 | 66.625 |
| 10:12 ET | 17477 | 66.4 |
| 10:14 ET | 2068 | 66.35 |
| 10:15 ET | 1858 | 66.42 |
| 10:17 ET | 2237 | 66.47 |
| 10:19 ET | 2535 | 66.335 |
| 10:21 ET | 2000 | 66.38 |
| 10:24 ET | 2700 | 66.3 |
| 10:26 ET | 1700 | 66.225 |
| 10:28 ET | 2500 | 66.275 |
| 10:30 ET | 2900 | 66.29 |
| 10:32 ET | 1500 | 66.23 |
| 10:33 ET | 2010 | 66.19 |
| 10:35 ET | 2500 | 66.206 |
| 10:37 ET | 2090 | 66.245 |
| 10:39 ET | 1778 | 66.31 |
| 10:42 ET | 1233 | 66.29 |
| 10:44 ET | 2466 | 66.23 |
| 10:46 ET | 1400 | 66.295 |
| 10:48 ET | 1200 | 66.3 |
| 10:50 ET | 1300 | 66.35 |
| 10:51 ET | 700 | 66.41 |
| 10:53 ET | 1509 | 66.35 |
| 10:55 ET | 5420 | 66.47 |
| 10:57 ET | 3766 | 66.61 |
| 11:00 ET | 25993 | 66.36 |
| 11:02 ET | 4308 | 66.55 |
| 11:04 ET | 2115 | 66.52 |
| 11:06 ET | 3222 | 66.56 |
| 11:08 ET | 2400 | 66.505 |
| 11:09 ET | 3759 | 66.52 |
| 11:11 ET | 1500 | 66.55 |
| 11:13 ET | 4348 | 66.405 |
| 11:15 ET | 2332 | 66.38 |
| 11:18 ET | 14933 | 66.26 |
| 11:20 ET | 6597 | 66.37 |
| 11:22 ET | 1121 | 66.35 |
| 11:24 ET | 2200 | 66.38 |
| 11:26 ET | 1807 | 66.27 |
| 11:27 ET | 4239 | 66.25 |
| 11:29 ET | 2087 | 66.24 |
| 11:31 ET | 3170 | 66.17 |
| 11:33 ET | 3440 | 66.26 |
| 11:36 ET | 3107 | 66.3 |
| 11:38 ET | 1507 | 66.31 |
| 11:40 ET | 4350 | 66.1925 |
| 11:42 ET | 7363 | 66.27 |
| 11:44 ET | 5276 | 66.34 |
| 11:45 ET | 3858 | 66.31 |
| 11:47 ET | 1856 | 66.325 |
| 11:49 ET | 1000 | 66.34 |
| 11:51 ET | 1690 | 66.335 |
| 11:54 ET | 29636 | 66.29 |
| 11:56 ET | 3400 | 66.39 |
| 11:58 ET | 2510 | 66.46 |
| 12:00 ET | 8629 | 66.41 |
| 12:02 ET | 2500 | 66.44 |
| 12:03 ET | 2125 | 66.45 |
| 12:05 ET | 1020 | 66.42 |
| 12:07 ET | 2201 | 66.37 |
| 12:09 ET | 1700 | 66.29 |
| 12:12 ET | 2347 | 66.33 |
| 12:14 ET | 4400 | 66.32 |
| 12:16 ET | 2467 | 66.29 |
| 12:18 ET | 2899 | 66.32 |
| 12:20 ET | 2200 | 66.26 |
| 12:21 ET | 2714 | 66.27 |
| 12:23 ET | 2100 | 66.23 |
| 12:25 ET | 1331 | 66.21 |
| 12:27 ET | 7258 | 66.23 |
| 12:30 ET | 3255 | 66.25 |
| 12:32 ET | 1216 | 66.095 |
| 12:34 ET | 2321 | 66.1 |
| 12:36 ET | 4010 | 66.135 |
| 12:38 ET | 1333 | 66.135 |
| 12:39 ET | 3368 | 66.115 |
| 12:41 ET | 2413 | 66.12 |
| 12:43 ET | 6300 | 66.07 |
| 12:45 ET | 2152 | 66 |
| 12:48 ET | 2600 | 66 |
| 12:50 ET | 2200 | 66.03 |
| 12:52 ET | 900 | 66.03 |
| 12:54 ET | 1400 | 66.01 |
| 12:56 ET | 2171 | 66 |
| 12:57 ET | 1403 | 66.01 |
| 12:59 ET | 22083 | 66 |
| 01:01 ET | 2300 | 65.98 |
| 01:03 ET | 1700 | 66.01 |
| 01:06 ET | 5054 | 66.015 |
| 01:08 ET | 2000 | 66 |
| 01:10 ET | 1723 | 65.98 |
| 01:12 ET | 2200 | 65.995 |
| 01:14 ET | 800 | 65.985 |
| 01:15 ET | 1812 | 66.015 |
| 01:17 ET | 1100 | 66.055 |
| 01:19 ET | 2505 | 66.08 |
| 01:21 ET | 2102 | 66.095 |
| 01:24 ET | 1000 | 66.09 |
| 01:26 ET | 900 | 66.11 |
| 01:28 ET | 1300 | 66.125 |
| 01:30 ET | 1900 | 66.17 |
| 01:32 ET | 2713 | 66.16 |
| 01:33 ET | 900 | 66.15 |
| 01:35 ET | 1209 | 66.18 |
| 01:37 ET | 1700 | 66.18 |
| 01:39 ET | 903 | 66.16 |
| 01:42 ET | 700 | 66.17 |
| 01:44 ET | 900 | 66.16 |
| 01:46 ET | 1830 | 66.17 |
| 01:48 ET | 1076 | 66.14 |
| 01:50 ET | 2800 | 66.225 |
| 01:51 ET | 913 | 66.23 |
| 01:53 ET | 2442 | 66.26 |
| 01:55 ET | 2207 | 66.21 |
| 01:57 ET | 1575 | 66.2 |
| 02:00 ET | 867 | 66.19 |
| 02:02 ET | 1100 | 66.15 |
| 02:04 ET | 1000 | 66.16 |
| 02:06 ET | 700 | 66.15 |
| 02:08 ET | 1947 | 66.12 |
| 02:09 ET | 2100 | 66.105 |
| 02:11 ET | 2700 | 66.16 |
| 02:13 ET | 1409 | 66.16 |
| 02:15 ET | 1515 | 66.15 |
| 02:18 ET | 700 | 66.16 |
| 02:20 ET | 600 | 66.17 |
| 02:22 ET | 2100 | 66.16 |
| 02:24 ET | 1416 | 66.1227 |
| 02:26 ET | 2397 | 66.09 |
| 02:27 ET | 2521 | 66.02 |
| 02:29 ET | 2318 | 66.07 |
| 02:31 ET | 2200 | 66.05 |
| 02:33 ET | 2731 | 66.02 |
| 02:36 ET | 1401 | 66 |
| 02:38 ET | 1651 | 65.95 |
| 02:40 ET | 2700 | 65.98 |
| 02:42 ET | 1100 | 65.97 |
| 02:44 ET | 3067 | 66 |
| 02:45 ET | 3452 | 66.045 |
| 02:47 ET | 5205 | 66.15 |
| 02:49 ET | 4500 | 66.18 |
| 02:51 ET | 8821 | 66.24 |
| 02:54 ET | 3300 | 66.21 |
| 02:56 ET | 4507 | 66.22 |
| 02:58 ET | 3083 | 66.25 |
| 03:00 ET | 3600 | 66.25 |
| 03:02 ET | 4209 | 66.275 |
| 03:03 ET | 5570 | 66.26 |
| 03:05 ET | 3794 | 66.23 |
| 03:07 ET | 6503 | 66.22 |
| 03:09 ET | 3159 | 66.235 |
| 03:12 ET | 5501 | 66.23 |
| 03:14 ET | 3972 | 66.18 |
| 03:16 ET | 5689 | 66.12 |
| 03:18 ET | 1505 | 66.12 |
| 03:20 ET | 2832 | 65.99 |
| 03:21 ET | 6151 | 65.99 |
| 03:23 ET | 3795 | 65.93 |
| 03:25 ET | 1800 | 65.83 |
| 03:27 ET | 3912 | 65.81 |
| 03:30 ET | 7905 | 65.855 |
| 03:32 ET | 2419 | 65.815 |
| 03:34 ET | 4921 | 65.815 |
| 03:36 ET | 4455 | 65.87 |
| 03:38 ET | 3644 | 65.86 |
| 03:39 ET | 4032 | 65.86 |
| 03:41 ET | 2966 | 65.86 |
| 03:43 ET | 15793 | 65.92 |
| 03:45 ET | 7815 | 65.97 |
| 03:48 ET | 7918 | 65.92 |
| 03:50 ET | 7049 | 65.925 |
| 03:52 ET | 9982 | 65.835 |
| 03:54 ET | 9672 | 65.845 |
| 03:56 ET | 27397 | 65.84 |
| 03:57 ET | 24590 | 65.885 |
| 03:59 ET | 378241 | 65.82 |
Sep 25, 2024
Sep 18, 2024
Incyte and Syndax Announce New England Journal of Medicine Publication of Data from Pivotal AGAVE-201 Trial of Niktimvo(TM) (axatilimab-csfr) in Chronic Graft-Versus-Host Disease, from 5:16PM ET on Wednesday Sep 18, 2024 by Dow Jones
5:16PM ET on Wednesday Sep 18, 2024 by Dow JonesDJ Incyte Cut to Hold From Buy by Truist Securities, from 8:07AM ET on Wednesday Sep 18, 2024 by Dow Jones
8:07AM ET on Wednesday Sep 18, 2024 by Dow Jones
Sep 16, 2024
DJ Incyte Is Maintained at Buy by Guggenheim, from 12:55PM ET on Monday Sep 16, 2024 by Dow Jones
12:55PM ET on Monday Sep 16, 2024 by Dow JonesDJ Incyte Is Maintained at Neutral by B of A Securities, from 8:30AM ET on Monday Sep 16, 2024 by Dow Jones
8:30AM ET on Monday Sep 16, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Incyte Corp | 12.5B | 186.1x | +39.11% |
Charles River Laboratories International Inc | 10.2B | 23.7x | +15.57% |
Exact Sciences Corp | 12.6B | -68.7x | --- |
Biomarin Pharmaceutical Inc | 13.4B | 53.2x | --- |
United Therapeutics Corp | 15.9B | 16.5x | +8.22% |
Neurocrine Biosciences Inc | 11.7B | 34.7x | +62.04% |
Company Information
Incyte Corporation is a biopharmaceutical company, which is focused on the discovery, development, and commercialization of therapeutics. The Company operates in two therapeutic areas, One therapeutic area is Hematology/Oncology, which is comprised of Myeloproliferative Neoplasms and Graft-Versus-Host Disease, as well as solid tumors and hematologic malignancies. Its other therapeutic area is Inflammation and Autoimmunity, which includes its Dermatology commercial franchise. Its hematology and oncology franchise are comprised of four products, which are JAKAFI (ruxolitinib), MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab), PEMAZYRE (pemigatinib), ICLUSIG (ponatinib), and ZYNYZ (retifanlimab-dlwr), as well as numerous clinical development programs. The Company's pipeline also includes two first-in-class small molecule antagonists targeting Mas-related G protein-coupled receptor X2 (MRGPRX2) for the treatment of various mast cell mediated disorders and MRGPRX4 for cholestatic pruritus.
Contact Information
- Headquarters
- 1801 Augustine Cut-OffWILMINGTON, DE, United States 19803
- Phone
- 302-498-6700
- Fax
- 302-636-5454
Executives
- Chairman of the Board, President, Chief Executive Officer
- Herve Hoppenot
- President and Head - Research and Development
- Pablo Cagnoni
- Chief Financial Officer, Executive Vice President
- Christiana Stamoulis
- Executive Vice President, General Counsel, Corporate Secretary
- Sheila Denton
- Executive Vice President, General Manager, Europe
- Jonathan Dickinson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $12.5B |
|---|---|
Revenue (TTM) | $3.9B |
Shares Outstanding | 192.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.73 |
EPS | $0.35 |
Book Value | $23.14 |
P/E Ratio | 186.1x |
Price/Sales (TTM) | 3.3 |
Price/Cash Flow (TTM) | 68.0x |
Operating Margin | 0.41% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
